Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31,2026.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Privi Speciality Chemicals reported audited standalone revenue of Rs. 2,45,553 lakhs for FY26, up 20.5% from Rs. 2,03,834 lakhs in FY25, meeting the 20% revenue growth threshold. Standalone net profit grew 20.8% to Rs. 14,710 lakhs from Rs. 12,176 lakhs. On a consolidated basis, revenue was Rs. 2,56,369 lakhs with net profit of Rs. 12,383 lakhs, though the three subsidiaries collectively posted a net loss of Rs. 3,586 lakhs which partially offset parent profitability. The Board recommended a final dividend of Rs. 10 per share (100% on Rs. 10 face value) totaling Rs. 3,906 lakhs, subject to shareholder approval at the August 2026 AGM. Statutory auditors BSR & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated results. The company operates in a single segment - aroma chemicals.
The 20%+ revenue and profit growth demonstrates solid operational performance in the aroma chemicals business. The clean audit opinion removes any immediate concerns about financial reporting quality. However, investors should monitor the subsidiary losses which are dragging consolidated results.